F. Waheed, M.D., R. Lerner, M.D., T. Ahmed, M.D., and K. Rashid, M.D.

Drs. Waheed and Rashid are Fellows in the Hematology & Oncology training program of the Department of Medicine of New York Medical College at Westchester Medical Center. Dr. Ahmed is Professor of Medicine and Chief of Oncology at New York Medical College and Director of the Zalmen A. Arlin Cancer Institute, Valhalla, NY. Drs. Waheed, Ahmed and Rashid report no comercial conflicts of interest.

Release Date: 04/21/2005
Termination Date: 04/21/2008

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, you should be able to:

• Discuss the role of high-dose chemotherapy in lymphoma
• Discuss the treatment options for patients with resistant lymphomas including tandem transplant
• Discuss the side effects of various chemotherapeutic agents used as conditioning chemotherapy and other complications associated with stem cell transplant.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity